Jonathan M Peacock's most recent trade in Avantor Inc. was a trade of 17,100 Common Stock done . Disclosure was reported to the exchange on May 8, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Avantor Inc. | Jonathan M. Peacock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 17,100 | 219,815 (0%) | 0% | 0 | Common Stock | |
Avantor Inc. | Jonathan M. Peacock | Director | Purchase of securities on an exchange or from another person at price $ 12.81 per share. | 28 Apr 2025 | 8,091 | 202,715 (0%) | 0% | 12.8 | 103,646 | Common Stock |
Avantor Inc. | Jonathan M. Peacock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 8,477 | 194,624 (0%) | 0% | 0 | Common Stock | |
Avantor Inc. | Jonathan M. Peacock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 9,808 | 186,147 (0%) | 0% | 0 | Common Stock | |
Avantor Inc. | Jonathan M. Peacock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 6,693 | 176,339 (0%) | 0% | 0 | Common Stock | |
Avantor Inc. | Jonathan M. Peacock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 1,215 | 169,646 (0%) | 0% | 0 | Common Stock | |
Bellerophon Therapeutics Inc | Jonathan M. Peacock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 15,308 | 157,033 (0%) | 0% | 0 | Common Stock | |
Avantor Inc. | Jonathan M. Peacock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 7,236 | 168,431 (0%) | 0% | 0 | Common Stock |